share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

Moderna | 4:持股變動聲明-高管 Klinger Shannon Thyme
美股SEC公告 ·  06/04 17:18
Moomoo AI 已提取核心訊息
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on June 3, 2024. The transaction involved the sale of 122 shares of Moderna's common stock at a price of $140.72 per share, resulting in a total sale value of $17,167.82. This sale followed an acquisition of 232 shares through the exercise of derivative securities on May 31, 2024. After these transactions, Klinger's direct holdings in Moderna stock amounted to 10,878 shares. The sale was conducted as an open market or private sale, according to the transaction details provided.
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on June 3, 2024. The transaction involved the sale of 122 shares of Moderna's common stock at a price of $140.72 per share, resulting in a total sale value of $17,167.82. This sale followed an acquisition of 232 shares through the exercise of derivative securities on May 31, 2024. After these transactions, Klinger's direct holdings in Moderna stock amounted to 10,878 shares. The sale was conducted as an open market or private sale, according to the transaction details provided.
莫德納首席法律官香農蒂米克林格於 2024 年 6 月 3 日完成公司股票的銷售。該交易涉及以每股 140.72 美元的價格出售莫代納普通股 122 股,總銷售價值為 17,167.82 美元。此次銷售後於 2024 年 5 月 31 日通過行使衍生性證券收購 232 股。在這些交易後,克林格對莫代納股票的直接持有 10,878 股。根據提供的交易詳細信息,銷售以開放市場或私人銷售進行。
莫德納首席法律官香農蒂米克林格於 2024 年 6 月 3 日完成公司股票的銷售。該交易涉及以每股 140.72 美元的價格出售莫代納普通股 122 股,總銷售價值為 17,167.82 美元。此次銷售後於 2024 年 5 月 31 日通過行使衍生性證券收購 232 股。在這些交易後,克林格對莫代納股票的直接持有 10,878 股。根據提供的交易詳細信息,銷售以開放市場或私人銷售進行。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息